Covidien Launches OneShot Renal Denervation System

Covidien COV today announced the commercial launch of the OneShot™ Renal Denervation System, an over the wire balloon-based irrigated catheter technology for the treatment of high blood pressure or hypertension. Covidien today announced the commercial launch of the OneShot Renal Denervation System, an over the wire balloon-based irrigated catheter technology for the treatment of high blood pressure. (Photo: Business Wire) Placed percutaneous, OneShot delivers radiofrequency (RF) energy in a circumferential manner to the renal arterial wall, and requires only a single treatment per artery. OneShot received the CE Mark in February 2012 and has been undergoing clinical trial evaluation in New Zealand and Europe. The product will be rolled out in Europe, Middle See full press release